Opening GPAtlas…

🌊 The Ocean Library · GP clinical topic

Meticillin-Resistant Staphylococcus Aureus (MRSA)

Written and reviewed by practising UK GPs, overseen by our Clinical Advisory Officer.

🧭 When to suspect

Meticillin-resistant Staphylococcus aureus (MRSA) is a strain of S. aureus resistant to the beta-lactam antibiotics – including the penicillins (such as flucloxacillin) and the cephalosporins – which makes it harder to treat than ordinary staphylococcal infection. The single most important distinction in primary care is colonisation versus infection: around one in thirty people carry MRSA harmlessly on the skin or in the nose, and carriage alone does not warrant systemic antibiotics.

Suspect MRSA in any skin or soft tissue infection (SSTI) – redness, swelling, warmth, pus, a boil or an abscess – that fails to respond to standard empirical antibiotics. Risk is higher with recent contact with a healthcare facility (hospital or care home), chronic wounds or leg ulcers, indwelling devices (urinary catheters, intravenous (IV) lines, percutaneous endoscopic gastrostomy (PEG) tubes), recent antibiotics, immunosuppression, or known close contact with MRSA.

Recurrent or multiple boils and abscesses – particularly in otherwise fit, young people, those in close-contact sports, or household clusters – should prompt consideration of Panton-Valentine leucocidin (PVL)-associated S. aureus, which may be meticillin-sensitive (MSSA) or MRSA.

Feature Colonisation (carriage) Infection
Clinical picture No symptoms – bacteria present without harm Local signs (redness, pus, abscess) Β± systemic features
Systemic antibiotics Not indicated Indicated for genuine infection, guided by sensitivities
Primary action Selective topical decolonisation and IPC where appropriate Drain and swab, treat per sensitivities, safety-net

🧠 Clinical pearl

Think PVL when boils and abscesses recur or appear in several sites, especially in a fit young adult, a wrestler or rugby player, or where a household member or teammate has the same problem. PVL is a toxin carried by fewer than 2% of S. aureus isolates and can sit on either MSSA or MRSA – so request PVL testing specifically on the form, because the laboratory will not look for it routinely.

Source: BSAC/BIA Β· UKHSA


πŸ”’ Sign up free to read the full topic

You're viewing a free preview. Create a free account to unlock the rest.

Sign up free β†’
Inside the full topic πŸ”’ HistoryπŸ”’ Red FlagsπŸ”’ ExaminationπŸ”’ Patient ExplanationπŸ”’ InvestigationsπŸ”’ ManagementπŸ”’ Non-pharmacological TreatmentπŸ”’ Pharmacological TreatmentπŸ”’ Special NotesπŸ”’ Referral PathwaysπŸ”’ Take Home Messages

Sample topics are open to everyone in the Free Sample Bundle.

Part of The Ocean Library, 450+ structured clinical topics mapped to the primary care curriculum. Companion audio in Echo Β· one-page summary in The Scope.

We use cookies to enhance your browsing experience, provide personalised content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Privacy policy